We aimed to investigate the activation of the IFNγ signaling pathway in monocytes of patients with sHLH/MAS and to evaluate whether levels of pSTAT1 could be used in a clinical setting to identify patients at early stages of HLH/MAS. This evidence concerns the gene IFNG and macrophage activation syndrome.